Bavarian Nordic — Februar 2021
-
Sanofi regnskab med tidligere Zealand Pharma produkt (Soliqua
/Suliqua
"Fourth-quarter Soliqua
/Suliqua sales increased 25.6% to €46 million driven by launches in Rest of the World. Fullyear 2020 Soliqua sales increased 36.1% supported by strong growth in all three regions." -
VectivBio er desværre ikke håbløst bagud ift. Zeal: https://finans.dk/erhverv/ECE12497236/novopengetank-udfordrer-zealand-pharmas-fremtidshaab/
-
Skrev jo ZP
den så oversolgt ud -op 3% -
Kan nogen bidrage med et link?
-
Det er måske 16.00 GMT....
-
haha'
-
Det var satme dumt. Beklager - synet er åbenbart begyndt at svigt. Jeg går i haven i sted
et..... -
LOLland:)
-
Verdens sjoveste land..:
-
Well m.fl. - gentager gerne, at VectivBio er PÆNT bagud i forhold til Zealand! Hvis ikke man i forvejen kender omfanget af de forskellige studier, så får I lige et link herunder; vh./god weekend! Essens: "Et fase III studie varer typisk flere år og inkluderer op til flere tusinde personer.", https://laegemiddelstyrelsen.dk/da/godkendelse/kliniske-forsoeg/hvad-er-et-klinisk-forsoeg/faser-i-kliniske-forsoeg/#
-
Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF (VectivBio)
144 participants
Study Completion Date: June 30, 2023
Pandemi + Readout + PDUFA. Måske 2025-26.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind